 Drugs, Generic
"Drugs, Generic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
| Descriptor ID |
D016568
|
| MeSH Number(s) |
D26.360
|
| Concept/Terms |
Drugs, Generic- Drugs, Generic
- Drugs, Nonproprietary
- Nonproprietary Drugs
- Generic Drugs
|
Below are MeSH descriptors whose meaning is more general than "Drugs, Generic".
Below are MeSH descriptors whose meaning is more specific than "Drugs, Generic".
This graph shows the total number of publications written about "Drugs, Generic" by people in this website by year, and whether "Drugs, Generic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2011 | 3 | 0 | 3 | | 2016 | 1 | 1 | 2 | | 2018 | 0 | 1 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drugs, Generic" by people in Profiles.
-
de Havenon A, Delic A, Dehoney S, Whetman P, Sheibani N, Callaghan B, Ney J, Esper GJ, Magliocco B, Nair KV. Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D. Neurology. 2021 04 20; 96(16):e2132-e2137.
-
Shaker M, Greenhawt M. Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis. JAMA Netw Open. 2018 11 02; 1(7):e184728.
-
Gastala NM, Wingrove P, Gaglioti A, Petterson S, Bazemore A. Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs. Health Aff (Millwood). 2016 07 01; 35(7):1237-40.
-
Kesselheim AS, Gagne JJ, Franklin JM, Eddings W, Fulchino LA, Avorn J, Campbell EG. Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey. J Gen Intern Med. 2016 06; 31(6):609-14.
-
Kahook MY, Fechtner RD, Katz LJ, Noecker RJ, Ammar DA. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry. Curr Eye Res. 2012 Feb; 37(2):101-8.
-
Holmes DR, Becker JA, Granger CB, Limacher MC, Page RL, Sila C. ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee. J Am Coll Cardiol. 2011 Sep 13; 58(12):1287-307.
-
Wu EQ, Yu AP, Lauzon V, Ramakrishnan K, Marynchenko M, Ben-Hamadi R, Blum S, Erder MH. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder. Ann Pharmacother. 2011 Apr; 45(4):441-51.
-
Christians U, Klawitter J, Clavijo CF. Bioequivalence testing of immunosuppressants: concepts and misconceptions. Kidney Int Suppl. 2010 Mar; (115):S1-7.
-
Bailey JE, Barton PL, Lezotte D, Lowenstein SR, Dart RC. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. Drug Alcohol Depend. 2006 Sep 15; 84(2):182-7.
-
Billups SJ, Plushner SL, Olson KL, Koehler TJ, Kerzee J. Clinical and economic outcomes of conversion of simvastatin to lovastatin in a group-model health maintenance organization. J Manag Care Pharm. 2005 Oct; 11(8):681-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|